In a medical sense, adherence refers to the extent to which a person’s behavior corresponds with mutually agreed recommendations from healthcare professionals. This includes taking medication, following a diet or agreed lifestyle changes. In clinical trials, adherence primarily concerns the protocol-compliant participation of trial participants in planned treatments, visits and data collections.<\/p>\n
The World Health Organization describes adherence as the correspondence of a person’s behavior with agreed recommendations from a healthcare provider. The emphasis is on “agreed”: the term recognizes the active role of the person and does not reduce treatment to mere obedience. Adherence can refer to taking an investigational medicinal product, using a medical device, attending appointments or performing protocol-specified measures.<\/p>\n
In a clinical trial, complete participation is not a prerequisite for respecting self-determination. Participants may terminate participation or individual aspects without being subjected to undue pressure. The study team should traceably document which data and measures are actually available and clarify medical questions individually. Low adherence is therefore initially information about actual exposure or data collection, not automatically misconduct by the affected person.<\/p>\n
How adherence is recorded must fit the study objective and participant burden. Protocols can specify, for example, the return and reconciliation of investigational medicinal products, dosing diaries, participant reports, appointment status or electronic data collection. Such details measure different aspects in each case. The return of medication, for example, documents inventory, but does not alone prove actual intake. The validity of a method and the handling of missing data should therefore be planned in advance.<\/p>\n
Responsibility at the investigational site includes understandable information about study-specific procedures, secure dispensing and return of investigational medicinal products as well as timely documentation. Abnormalities can be caused medically, organizationally or by the trial burden. A risk-based process therefore investigates causes without blaming participants or pressuring them to continue. In case of safety-relevant symptoms, medical assessment and appropriate care take precedence over data collection.<\/p>\n
If actual use deviates significantly from the planned treatment, this can influence the interpretation of efficacy and safety data. Missed visits or missing information can also alter the data situation. This does not mean that every deviation explains the benefit or risk of an investigational medicinal product. The analysis must consider what was measured, how reliable the information is and whether drop-outs occur differently between groups.<\/p>\n
Good trial design can reduce avoidable burden. ICH E8(R1) requires considering quality already during planning and identifying critical factors. This can include a comprehensible visit schedule, realistic procedures, appropriate reminders and clear contact options for questions. Digital tools are only useful if data protection, accessibility and the burden on the target population are taken into account. They do not replace personal medical care.<\/p>\n
In the GxP and GCP context, compliance describes the rule conformity of organizations and persons planning or conducting a clinical trial. This means adherence to the protocol, standard operating procedures, GCP and applicable regulatory requirements. The term relates, for example, to the sponsor, investigator, investigational site, CRO and their systems. Identified non-compliance may require corrective and preventive actions.<\/p>\n
Adherence, on the other hand, means the treatment compliance or participation of a patient or trial participant. The words are occasionally mixed up in everyday language, but refer to different levels. A participant who misses a dose is not “non-compliant” in the same sense as a site that fails to process required safety reports. This differentiation protects against inappropriate assignment of blame and keeps responsibilities clear in quality management.<\/p>\n
Adherence is significant for the validity and safety of a clinical trial because it makes the actually performed intervention and the completeness of planned observations visible. Crucial factors are a proportionate, pre-described collection and respectful interaction with participants. Documentation must distinguish between participant reports, inventory reconciliations and medical assessments, instead of drawing premature conclusions from individual data points.<\/p>\n
Full-service CROs such as Mediconomics support the planning of feasible visit and data collection procedures, training of investigational sites, data management and quality control of study-specific adherence data. They also help align protocol requirements, drug accountability, participant communication and the analysis of missing data so that safety and data integrity are considered.<\/p>\n
Is adherence the same as taking all prescribed doses?<\/strong><\/p>\n No. Intake is an important partial aspect. Adherence can also include agreed visits, diet specifications or other measures and describes the correspondence with mutually agreed recommendations.<\/p>\n May an investigational site pressure participants for better adherence?<\/strong><\/p>\n No. Information, support and medical clarification are permissible and useful. Participation remains voluntary; undue pressure or inappropriate influence contradict the principles of clinical research.<\/p>\n Is a forgotten dose a GCP deviation by the participant?<\/strong><\/p>\n It can be relevant for trial data and should be recorded according to the protocol. GCP compliance in the organizational sense, however, concerns the compliant conduct by responsible organizations and professionals.<\/p>\n In a medical sense, adherence refers to the extent to which a person’s behavior corresponds with mutually agreed recommendations from healthcare professionals. This includes taking medication, following a diet or agreed lifestyle changes. In clinical trials, adherence primarily concerns the protocol-compliant participation of trial participants in planned treatments, visits and data collections. Adherence as treatment […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[],"class_list":["post-6889","glossary","type-glossary","status-publish","hentry"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":2,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6889\/revisions"}],"predecessor-version":[{"id":7432,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6889\/revisions\/7432"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=6889"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=6889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory references<\/h2>\n
\n